论文部分内容阅读
目的:探究布地奈德联合阿奇霉素治疗小儿肺炎支原体感染的临床疗效。方法:选取2016年7月~2017年7月期间在我院进行治疗的肺炎支原体感染患儿,共抽取86例,将其采取随机数字表法分成对照组和观察组。对照组43例患儿,采用阿奇霉素治疗;观察组43例患儿,在对照组治疗基础上,给予雾化吸入布地奈德混悬液进行治疗。观察两组患儿治疗后其各项临床指标以及治疗效果。结果:观察组患儿的咳嗽、发热、肺部啰音等症状消失时间和住院时间均短于对照组,治疗总有效率(95.35%)高于对照组(76.74%),比较差异均具有统计学意义(P<0.05)。结论:采用布地奈德联合阿奇霉素治疗小儿肺炎支原体感染,其疗效显著,值得推广。
Objective: To investigate the clinical efficacy of budesonide combined with azithromycin in the treatment of Mycoplasma pneumoniae infection in children. Methods: A total of 86 children with Mycoplasma pneumoniae infection were selected from July 2016 to July 2017 in our hospital. They were divided into control group and observation group by random number table. In the control group, 43 children were treated with azithromycin. In the observation group, 43 children were treated with inhalation of budesonide by inhalation on the basis of the control group. After treatment, the clinical indexes and the therapeutic effects of the two groups were observed. Results: The disappearance time and hospitalization time of cough, fever and pulmonary rales in observation group were shorter than those in control group. The total effective rate (95.35%) in observation group was higher than that in control group (76.74%), with statistical difference Significance (P <0.05). Conclusion: Budesonide combined with azithromycin in children with Mycoplasma pneumoniae infection, its significant effect, it is worth promoting.